2022
DOI: 10.1016/j.ymthe.2022.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Moving targets: COVID-19 vaccine efficacy against Omicron subvariants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Some countries had other problems such as vaccine hesitancy, for instance, Bulgaria reported a hesitancy level of 62% and Poland reported a similar issue in older age cohorts [9]. On the other hand, available data by July 2022 suggest that variants of COVID-19 specifically the BA.2, BA.4, and BA.5 subvariants escape neutralizing antibodies to a significant extent, which complicated the transmission of the pandemic [10][11][12][13][14][15][16][17].…”
Section: Introductionmentioning
confidence: 99%
“…Some countries had other problems such as vaccine hesitancy, for instance, Bulgaria reported a hesitancy level of 62% and Poland reported a similar issue in older age cohorts [9]. On the other hand, available data by July 2022 suggest that variants of COVID-19 specifically the BA.2, BA.4, and BA.5 subvariants escape neutralizing antibodies to a significant extent, which complicated the transmission of the pandemic [10][11][12][13][14][15][16][17].…”
Section: Introductionmentioning
confidence: 99%
“…This includes the current challenge posed by the novel coronavirus 5 . These alarming statistics highlight the need to raise awareness and take action to prevent the spread of these diseases 6 , 7 . Vaccination is an important strategy to prevent these diseases, and immunoinformatics promises to revolutionize the field of vaccine development 8 – 13 .…”
mentioning
confidence: 99%